US FDA approves Teva Pharmaceuticals' generic obesity drug – Reuters

Written by

admin

in

  1. US FDA approves Teva Pharmaceuticals’ generic obesity drug  Reuters
  2. Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss  Yahoo Finance
  3. US FDA approves Teva Pharmaceuticals’ generic obesity drug  The Mighty 790 KFGO
  4. This Pharma Stock Is Down 19% In 2025 But Just Received An ‘Explosive News’ – Find Out More  Stocktwits
  5. BRIEF—Teva wins FDA nod and launches generic Saxenda, first generic GLP-1  The Pharma Letter

Continue Reading

More posts